Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CAI
KYMR
Add up to 3 more stocks
CAI
Caris Life Sciences, Inc.
-9.66%
$27.45-2.94Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$7.76B
52W Range
$14.19 - $33.66
KYMR
Kymera Therapeutics, Inc.
-3.52%
$105.98-3.87Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$8.72B
52W Range
$55.26 - $130.05
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 76.71 | N/A |
| Forward P/E | 236.62 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.12 | 5.78 |
| P/S Ratio | 7.84 | 83.03 |
| P/FCF Ratio | 52.98 | N/A |
| EV/EBITDA | 43.23 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 69.7% | 102.0% |
| Operating Margin | 5.6% | -891.3% |
| Net Margin | 10.6% | -285.4% |
| ROE | 17.8% | -19.9% |
| ROA | 8.6% | -18.2% |
| ROIC | 14.8% | -22.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.53 | 9.83 |
| Quick Ratio | 4.88 | N/A |
| Debt/Equity | 0.76 | 0.05 |
| Interest Coverage | 0.79 | -1403.21 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.